Moreover, the administration of LysoPA to LDR-/- apoB100/100 IGFII mice increased the osteogenic activity in the aortic valve and accelerated the development of CAVD [15,38]. This evidence concerns the gene IGF2 and congenital bilateral aplasia of vas deferens from CFTR mutation.